The Food and Drug Administration’s decision to require a black box warning (the strongest warning that FDA puts on a drug) on all fast-acting opioid pain medicines is the latest step in the effort to fight the growing epidemic of opioid addiction.
The black-box warnings are aimed at more than 200 of these fast-acting or immediate release drug formulations which represent ninety percent (90%) of all opioid prescriptions e.g. oxycodone, hydrocodone and morphine. Read article here….
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.